Kratom, a substance acting on opioid receptors, is easily accessible and has sparked significant discussions. Originating from a tree native to Southeast Asia, people have chewed its leaves or brewed them for a tea providing stimulating effects. In the U.S., its sale has expanded into a billion-dollar industry with products available online and in numerous retail locations, including gas stations.
Proponents of the kratom industry tout it as a mild stimulant that aids opioid addiction recovery, supported by advocacy groups like the American Kratom Association. This group portrays kratom as a safe herbal supplement beneficial for health and energy. Its legal status is upheld in most states with backing from influential government figures.
However, health experts highlight significant dangers associated with kratom. Dr. Andrew Kolodny of Brandeis University asserts that kratom has effects similar to opioids like oxycodone, heroin, and fentanyl. The CDC has identified kratom in over 5,000 overdose deaths from 2020 to 2024.
The deaths of several young men, who used kratom for perceived benefits, underscore these risks. For instance, Susan Eppard recounted the tragic death of her son Matthew, who collapsed and died with mitragynine – kratom’s main opioid – solely implicated. Wendy Chamberlain similarly shared the story of her son Joe, whose death was attributed to mitragynine.
Justin Brower, a toxicologist from NMS Labs, indicated kratom-related fatalities have increased tenfold since 2014. He noted the growth in kratom use across the U.S. over the last decade. The FDA warns against kratom due to risks of liver toxicity, seizures, and substance use disorders.
Despite these warnings, the Department of Health and Human Services recently suggested increasing allowable 7-OH – a concentrated kratom derivative – by 20 times, a decision that surprised some health officials. Public records reveal substantial lobbying efforts by the American Kratom Association, similar to those by Purdue Pharma, to influence regulatory decisions. Millions have been spent to keep kratom legal through lobbying and political contributions.
Susan Eppard, disheartened that kratom remains on shelves, often shares her story with store clerks unaware of its potential dangers. She and others cope with the devastating loss attributed to this easily obtainable substance.

The Future of MAHA in American Health Politics
Insulin Cost Caps Gaining Support Amid Rising Prices
Efforts to Counter Food Assistance Cutbacks in San Diego
A Personal Journey Through Encephalitis
Low-Cost Medication May Benefit Stroke Survivors
Florida’s Struggle with Dengue Fever and AI Solutions